T6	Subject 78 142	men with metastatic castration-resistant prostate cancer (mCRPC)
T8	Treatment 0 55	Abiraterone acetate, an androgen biosynthesis inhibitor
T9	Gender 78 81	men
T11	Drug 0 19	Abiraterone acetate
T12	Treat-Disorder 87 134	metastatic castration-resistant prostate cancer
T7	Potential_therapeutic_event 57 74	prolongs survival
E1	Potential_therapeutic_event:T7